| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba882f7a712060104378944da0ac6fb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5a8e881c80843e383e888fb962c22ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_153c503fcd0547239e3d368755b0e80b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef9b53ab86bc806c49aee115833a4d54 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2011-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f46b0226370fd04a259643bda569b37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa94a96dd8b45d9211175679f54b4d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f138283554e209fe9c72b7fe7db08c3b |
| publicationDate |
2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012061833-A1 |
| titleOfInvention |
Compositions and methods for treating myelofibrosis |
| abstract |
Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N- tert -butyl-3-[(5-methyl-2-{ [4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4- yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10391094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8604042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102233757-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150123248-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016510065-A |
| priorityDate |
2010-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |